Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?

  • Leslie Citrome
  • Published 2012 in Clinical schizophrenia & related psychoses


OBJECTIVE To describe the efficacy, safety and tolerability of lurasidone for the acute treatment of schizophrenia using the metrics number needed to treat (NNT) and number needed to harm (NNH). METHODS Study data were pooled from six Phase II and III, 6-week, randomized, placebo-controlled trials that were conducted to test the efficacy and safety of… (More)
DOI: 10.3371/CSRP.6.2.5